Alan G.  Quasha net worth and biography

Alan Quasha Biography and Net Worth

Director of AdaptHealth
Alan Quasha is the Chief Executive Officer of Quadrant Management, Inc., the predecessor of which was founded in 1978. Mr. Quasha has also been a Partner of Vanterra Capital LLC since 2008 and an Investment Committee Member of Trilantic Capital Partners Fund IV since 2009. He serves as a board member of numerous companies, including his roles as Chairman of Carret Asset Management, LLC since 2004, Chairman of Brean Capital, LLC since 2005, Non-Executive Director of Compagnie Financiere Richemont SA (SWISS: CFR.VX) since 2000 and ARC Group Worldwide, Inc. since 2016, where he also serves as the Chief Executive Officer. As a venture capital investor, Mr. Quasha brings strategic and financial experience to our board of directors. He has evaluated and invested in numerous companies in the U.S. and emerging markets, across various industries. Many of these investments involved significant hands-on operating experience. He is also Chairman of the Brain Trauma Foundation, was a past Director of American Express Funds and a former Governor of the American Stock Exchange. Mr. Quasha holds a bachelor’s degree from Harvard College, an MBA from Harvard Business School, a Master of Law degree from New York University Law School and a Doctorate of Law from the Harvard Law School.

What is Alan G. Quasha's net worth?

The estimated net worth of Alan G. Quasha is at least $111,252.96 as of May 11th, 2021. Mr. Quasha owns 11,886 shares of AdaptHealth stock worth more than $111,253 as of April 19th. This net worth approximation does not reflect any other investments that Mr. Quasha may own. Learn More about Alan G. Quasha's net worth.

How do I contact Alan G. Quasha?

The corporate mailing address for Mr. Quasha and other AdaptHealth executives is 220 West Germantown Pike Suite 250, Plymouth Meeting PA, 19462. AdaptHealth can also be reached via phone at (610) 424-4515 and via email at [email protected]. Learn More on Alan G. Quasha's contact information.

Has Alan G. Quasha been buying or selling shares of AdaptHealth?

Alan G. Quasha has not been actively trading shares of AdaptHealth over the course of the past ninety days. Most recently, on Tuesday, May 11th, Alan G. Quasha bought 1,000 shares of AdaptHealth stock. The stock was acquired at an average cost of $24.64 per share, with a total value of $24,640.00. Following the completion of the transaction, the director now directly owns 11,886 shares of the company's stock, valued at $292,871.04. Learn More on Alan G. Quasha's trading history.

Who are AdaptHealth's active insiders?

AdaptHealth's insider roster includes Jason Clemens (CFO), Stephen Griggs (CEO), Ronald Mcdaniel (Director), Frank Mullen (CAO), Alan Quasha (Director), Shaw Rietkerk (COO), and Dale Wolf (Director). Learn More on AdaptHealth's active insiders.

Are insiders buying or selling shares of AdaptHealth?

In the last year, AdaptHealth insiders bought shares 1 times. They purchased a total of 720 shares worth more than $10,152.00. In the last year, insiders at the sold shares 5 times. They sold a total of 527,501 shares worth more than $6,709,619.15. The most recent insider tranaction occured on March, 11th when Major Shareholder James E Flynn sold 182,607 shares worth more than $2,012,329.14. Insiders at AdaptHealth own 13.6% of the company. Learn More about insider trades at AdaptHealth.

Information on this page was last updated on 3/11/2024.

Alan G. Quasha Insider Trading History at AdaptHealth

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/11/2021Buy1,000$24.64$24,640.0011,886View SEC Filing Icon  
See Full Table

Alan G. Quasha Buying and Selling Activity at AdaptHealth

This chart shows Alan G Quasha's buying and selling at AdaptHealth by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

AdaptHealth Company Overview

AdaptHealth logo
AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also offers wheelchairs, hospital beds, oxygen concentrators, CPAP masks and related supplies, wound care supplies, diabetes management supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.
Read More

Today's Range

Now: $9.36
Low: $9.21
High: $9.81

50 Day Range

MA: $9.78
Low: $7.10
High: $11.51

2 Week Range

Now: $9.36
Low: $6.37
High: $15.37

Volume

924,477 shs

Average Volume

1,103,721 shs

Market Capitalization

$1.24 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.02